Development of Rifapentine Susceptibility Tests for Mycobacterium tuberculosis
- 1 January 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (1) , 25-28
- https://doi.org/10.1128/aac.43.1.25
Abstract
Two methods for testing the susceptibility of Mycobacterium tuberculosis to rifapentine have been developed: the agar proportion method and the radiometric BACTEC technique. A critical concentration of 0.5 μg of rifapentine per ml is proposed for both methods since it provides a reliable means of distinguishing between susceptible and resistant M. tuberculosis isolates. It is recommended that two quality control M. tuberculosis strains be used at the introduction of these tests in a clinical laboratory: one that is pansusceptible (H37Rv) and one that is resistant to rifapentine. The resistant strain can be obtained from the American Type Culture Collection, where it is deposited under the number ATCC 700457.Keywords
This publication has 13 references indexed in Scilit:
- Clinical mycobacteriology. Drug susceptibility testing.1996
- Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophagesAntimicrobial Agents and Chemotherapy, 1995
- Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosisTubercle and Lung Disease, 1992
- Activityin vitroof Rifabutin, FCE 22807, Rifapentine, and Rifampin againstMycobacterium microtiandM. tuberculosisand Their Penetration into Mouse Peritoneal MacrophagesAmerican Review of Respiratory Disease, 1992
- Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in miceAntimicrobial Agents and Chemotherapy, 1991
- Bactericidal ActivityIn Vitroof Various Rifamycins againstMycobacterium aviumandMycobacterium tuberculosisAmerican Review of Respiratory Disease, 1990
- In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisTubercle, 1987
- Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparison of the sensitivity of mycobacteria to the cyclopentyl rifamycin DL473 and rifampicinJournal of Antimicrobial Chemotherapy, 1982
- Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.The Journal of Antibiotics, 1981